References: |
1. Weiss EP, Shah K, Fontana L, Lambert CP, Holloszy JO, Villareal DT (2009) Dehydroepiandrosterone replacement therapy in older adults; 1-2y effects on bone. Am J Clin Nutr. 89(5): 1459-67 (0798/lr/0001). 2. Noordam C, Dhir V, McNelis JC , Schlereth F, Hanley NA, Krone N, Smetitink JA, Smeets R, Sweep FCGJ, Claahsen-van der Griten HL, Arlt W (2009) Inactivating PAPSS2 metations in a patients with premature pubarche. The New England Journal of Medicine. 360:2310-8 (0798/lr/0002). 3. Gray NE, Liu X, Choi R, Blackman MR, Arnold JT (2009) Endocrine-immune-paracrine interactions in prostate cells: A model for mechanistic studies of phytomedicines. Cancer Prev Res (Phila PA). 2(2): 134-42 (0798/lr/0003). 4. Fitzpatrick JL, Ripp SL, Smith NB, Pierce WM Jr, Prough R (2001) Metabolism of DHEA by cytochromes P450 in rat amd human liver microsomal fractions. Archives of Biochemistry and Biophysics. 389(2): 278-87 (0798/lr/0004). 5. Matsuzaki Y, Yoshida S, Honda A, Miyazaki T, Tanaka N, Takagiwa A, Fujimoto Y, Miyazaki H. Simultaneous determination of Dehydropiandrosterone and its 7-oxygenated metabolites in human serum by high- resolution gas chromatography |